Customs delays can derail clinical trials in days. Learn practical strategies for import compliance, digital preclearance, and resilient cross-border logistics.
- Cold Chain Excellence: Safeguarding Biologics, Cell Therapies, And Temperature-Sensitive Products In Complex Logistics
- How AI Can Improve Clinical Supply Chain Visibility
- The Overlap Nobody Talks About: Packaging Decisions And Stability Budgets
- The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
- Study Start-Up Is Where Clinical Supply Risk Is Actually Decided
- How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies
- Clinical Trial Operations, Investigational Product Management, And The Foundation For Effective Risk Management
- Building Trust In Clinical Supply Digital Transformation
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Automation Testing In RTSM Software: What Is It And What's The Impact
Move beyond the limitations of manual oversight to see how automated frameworks ensure precision, speed, and reliability for the most sophisticated and adaptive clinical trial designs.
-
Treating Deficiencies In Employee Training And Mentorship
Investing in employee training and development is not just beneficial for the employees. It also contributes significantly to the organization’s success and competitive advantage.
-
How Modern Software Architecture Is Revolutionizing IRT Solutions
Explore the ways technology suppliers across the clinical trial space have begun investing in IRTs built around a microservices model capable of improving data access and visibility.
-
Is Your Clinical Supply Chain Fully Optimized?
Streamlined supply chain operations alleviate staff workload and significantly reduce IP waste. With the right partners, you can create a fully optimized, cost-effective supply chain strategy.
-
What Are Decentralized Clinical Trials (DCTs)?
Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.
-
How A Rare Disease Biotech Replaced Manual Processes With RTSM Software
Discover how a clinical-stage biotech automated its supply chain to protect patient enrollment and eliminate manual errors in a complex, multi-national genetic medicine trial.
-
Controlled Substances In Clinical Trials
Handling controlled substances presents layers of complexity. Partnering with an experienced CDMO is essential for managing scheduled materials during clinical studies.
-
What To Look For In Your IRT/RTSM Solution For A Simpler Trial Execution
Which factors should you consider when selecting an IRT/RTSM vendor to ensure your trial's randomization and supply management processes are successfully executed?
-
Navigating Audit Trail Data Regulations And Accessibility Changes
Data is the single most important thing in a clinical trial. Leverage the power of clinical trial data with effective utilization and access in a changing regulatory landscape.
-
How Life Sciences Leaders Are Preparing For More Curveballs In 2026
Anticipate regulatory shifts and supply chain hurdles with agile scenario planning. Move beyond fragmented systems to build a resilient, data-driven foundation for a volatile industry landscape.
- The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
- How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies
- First Advisors In: Meet Clinical Supply Leader's Inaugural Board Members
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 3 – Staying Aligned in a Moving System
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.